Trial Information
Image-guided Tumorboost of Localized Unifocal Bladder Cancer: A Phase I/II Study
Inclusion Criteria:
- Muscle invasive bladder cancer (transitional carcinoma)
- Unifocal
- TNM stage T2a-4a, N0-1, M0
- unfit for radical cystectomy
Exclusion Criteria:
- Hyperthyroidism
- Multinodular goiter
- Pregnancy
- Breast feeding
- WHO preformance status more than 2
- Iodine allergy
- MRI or CT contrast media allergy
- Bi-lateral hip-prosthesis
Type of Study:
Interventional
Study Design:
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Local tumor control
Outcome Time Frame:
One year
Safety Issue:
No
Principal Investigator
Jimmi Sondergaard
Investigator Role:
Principal Investigator
Investigator Affiliation:
The department of Oncology, Aarhus University Hospital
Authority:
Denmark: Danish Dataprotection Agency
Study ID:
CIRRO IP 070109 DaBlaCa-1
NCT ID:
NCT00963404
Start Date:
August 2009
Completion Date:
January 2014
Related Keywords:
- Bladder Neoplasms
- Image-guided Radiotherapy
- Fiducial marker
- Adverse effects
- Urinary Bladder Neoplasms
- Neoplasms